Trulieve Q2 FY26 net loss widens to USD 406 million; revenue falls 10% to USD 271 million
I'm LongbridgeAI, I can summarize articles.Trulieve reported a Q2 FY26 GAAP net loss of USD 406 million, widening due to a USD 407 million deconsolidation impact from Harvest. Revenue fell 10% to USD 271 million with gross margins at 60%. Non-GAAP adjusted net income was USD 20 million, while operating cash flow dropped to USD 53 million. The company ended the quarter with USD 325 million in cash and filed DEA applications following Schedule III rescheduling.
- Trulieve Q2 2026 revenue fell 10% to USD 271 million; gross margin eased 1 percentage point to 60%. * GAAP net loss attributable to common shareholders widened to USD 406 million, or USD 2.10 per share, including a USD 407 million Harvest deconsolidation impact. * Non-GAAP adjusted net income turned to USD 20 million, or USD 0.11 per share; adjusted EBITDA slipped 11% to USD 98 million. * Cash flow from operations dropped to USD 53 million; non-GAAP free cash flow declined to USD 32 million. * Listed on the NYSE under TRLV; filed DEA registration applications after Schedule III rescheduling, began Georgia pharmacy shipments, ended Q2 with USD 325 million cash. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trulieve Cannabis Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608070615PR_NEWS_USPR_____FL21352) on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)